Journal profile · Medicine-Hematology
Mediterranean Journal of Hematology and Infectious Diseases
ISSN 2035-3006 · Universita Cattolica del Sacro Cuore · Italy
Mediterranean Journal of Hematology and Infectious Diseases: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.27; fully open access; APC charged, amount not published; median 46 days to acceptance (97 articles, last 24 months); 68 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Mediterranean Journal of Hematology and Infectious Diseases is published by Universita Cattolica del Sacro Cuore and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Hemoglobinopathies and Related Disorders, Acute Myeloid Leukemia Research and Lymphoma Diagnosis and Treatment, together about 28.7% of its articles. Its main subfields are Hematology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Reciprocal interdependence between infectious and hematologic diseases (malignant and non-malignant) is well known. This relationship is particularly evident in Mediterranean countries. Parasitosis as Malaria, Leishmaniosis, B Hookworms, Teniasis, very common in the southeast Mediterranean area, infect about a billion people and manifest prevalently with anemia so that they are usually diagnosed mostly by experienced hematologist on blood or bone marrow smear. On the other hand, infections are also a significant problem in patients affected by hematological malignancies. The blood is the primary vector of HIV infection, which otherwise manifest with symptoms related to a reduction in T lymphocytes. In turn, infections can favor the insurgency of hematological malignancies. The causative relationship between Epstein-Barr virus infection, Helicobacter pylori, hepatitis C virus, HIV and lymphoproliferative diseases is well known.
Source: LetPub
Research area (LetPub): Medicine-Hematology
Editor-in-chief Giuseppe LeonePublisher website
Editorial board by country: none in mainland China; most named Italy 29, United States 4, India 2, Greece 2, United Kingdom 1 (47 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hemoglobinopathies and Related DisordersMedicine13.1%
- Acute Myeloid Leukemia ResearchMedicine9.2%
- Lymphoma Diagnosis and TreatmentMedicine6.5%
- Iron Metabolism and DisordersMedicine5.7%
- Chronic Lymphocytic Leukemia ResearchMedicine5.7%
- Blood groups and transfusionMedicine5.5%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine5.1%
- Acute Lymphoblastic Leukemia researchMedicine5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 3 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
| Minor | Infectious Diseases | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
Other: Journal Citation Reports/InCites, EuroPub Database
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.27LetPub ·
- Impact factor (publisher)
- 2.3Publisher website ·
- CiteScore 2026-06
- 3.2LetPub ·
- CiteScore (publisher)
- 3.2Publisher website ·
- SJR 2026-06
- 0.54LetPub ·
- SNIP 2026-06
- 0.73LetPub ·
- h-index
- 23LetPub ·
- h-index
- 59OpenAlex ·
- i10-index
- 519OpenAlex ·
- 2-year mean citedness
- 1.55OpenAlex ·
- Self-citation rate
- 8.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 44LetPub ·
Articles by year OpenAlex count · 1,235 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 75 | 75 | 10 |
| 2025 | 68 | 68 | 86 |
| 2024 | 90 | 90 | 265 |
| 2023 | 64 | 64 | 299 |
| 2022 | 84 | 84 | 462 |
| 2021 | 54 | 54 | 588 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
46 daysMedian, submission to acceptance · P25–P75 31 days – 82 days
- Acceptance to online
- median 19 days (99 articles)
- Submission to online
- median 70 days
- Sample
- 97 articles with submission and acceptance dates (162 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Unspecified peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 800 | No | CC BY-NC | |
| OpenAlex | EUR 600 | — | — | |
| LetPub | EUR 600 | No | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePeer review
- Peer review
The journal has been selected for coverage in Clarivate Analytics products and services beginning with V. 7 (1) 2015. Model summary
The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Universita Cattolica del Sacro Cuore
- Country or region
- Italy
- Language
- English
- ISSN
- 2035-3006
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Mediterranean Journal of Hematology and Infectious Diseases
What CAS zone is Mediterranean Journal of Hematology and Infectious Diseases in?
In the 2025 upgraded edition of the CAS Journal Ranking, Mediterranean Journal of Hematology and Infectious Diseases is in Zone 4 of Medicine, and in Zone 4 of the minor category Hematology / Infectious Diseases. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Mediterranean Journal of Hematology and Infectious Diseases?
The latest impact factor listed by LetPub is 2.27; CiteScore 3.2, h-index 59.
How long does peer review take at Mediterranean Journal of Hematology and Infectious Diseases?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 46 days (interquartile range 31–82 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Mediterranean Journal of Hematology and Infectious Diseases based?
Of the 47 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Italy (29), United States (4) and India (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Mediterranean Journal of Hematology and Infectious Diseases?
According to LetPub and DOAJ records, Mediterranean Journal of Hematology and Infectious Diseases is indexed in SCIE, Scopus and DOAJ. The journal's website also lists PubMed; that list has not been checked against each database.
Is Mediterranean Journal of Hematology and Infectious Diseases open access, and what is the APC?
Mediterranean Journal of Hematology and Infectious Diseases is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .